New Publication Online Highlighted Article in ELSEVIER Antiviral Research March 2022 Loss of hepatitis D virus infectivity upon farnesyl transferase inhibitor treatment associates with increasing RNA editing rates revealed by a new RT-ddPCR method. Verrier ER, Salvetti A, Pons C, Michelet M, Rivoire M, Baumert TF, Durantel D, Lucifora J.Antiviral Res. 2022 Feb;198:105250. doi: 10.1016/j.antiviral.2022.105250. Epub 2022 Jan 17.PMID: 35051490 This research article is the result of a long collaboration between our own Prof. Baumert and Dr. Verrier and scientists from CIRI – Centre International de Recherche en Infectiologie (INSERM U1111 / CNRS UMR5308 / ENS-L / UCB-Lyon) in Lyon.Find the highlights here: Antiviral Research - Highlights